Pharmaceuticals Specialty Analyst Suvannavejh, along with Key Opinion Leader, Dr. Rodney Schlosser, discuss Insmed (INSM) Brensocatib’s Potential in CRSsNP on an Analyst/Industry conference call to be held on December 15 at 1 pm.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INSM: